BioElectronics signs contract with YesDTC Holdings to enter the Japanese market

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the signing of a contract with YesDTC Holdings, Inc. (YESD.OB) to enter the Japanese market and receipt of the single largest product order and revenue commitment in company history.

“We are very excited about our entry into the Japanese market as we believe consumers will be highly receptive to our drug-free pain relieving and healing technology”

Shipments of initial products are expected to begin in the first quarter of 2010 with additional shipments expected throughout the year.

“We are very excited about our entry into the Japanese market as we believe consumers will be highly receptive to our drug-free pain relieving and healing technology,” said Arnon Horev, BioElectronics Vice President of Marketing. “The initial order being placed via our Japanese distributor is far and away our single biggest order we have ever received and well into six figures. We plan on recognizing part of this order in Q4:09 with the remaining portions and Q1:10 and Q2:10 and to realize additional revenues through the rest of 2010. The realization of a significant portion of this revenue in Q4:09 will allow us to further strengthen our already strong balance sheet. We welcome YesDTC Holdings to our growing ranks of premium international distributors for our award winning pain relieving and healing products.”

“At BioElectronics we are aggressively moving into many international markets,” Horev said. “As we have previously indicated, we have major initiatives underway in Latin America, Europe, Canada, and China among other international markets. We are expecting to begin airing television commercials in China during the first quarter of 2010 in support of our marketing efforts in that region and we are preparing to enter the Japanese market through our new distribution partner, YesDTC Holdings.”